HILLSIDE, NJ / ACCESS Newswire / September 23, 2025 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2025. Revenue for the quarter ended June 30, 2025 was $14.2 million compared to$12.7 million for the quarter ended June 30, 2024, an increase of $1.5 million or 11.8%. ...